{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:57:48Z","timestamp":1785416268646,"version":"3.56.0"},"reference-count":36,"publisher":"Japanese Circulation Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2019,2,25]]},"DOI":"10.1253\/circj.cj-18-1044","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T17:37:24Z","timestamp":1549474644000},"page":"662-671","source":"Crossref","is-referenced-by-count":13,"title":["Impact of Therapeutic Angiogenesis Using Autologous Bone Marrow-Derived Mononuclear Cells Implantation in Critical Limb Ischemia With Scleroderma\u3000\u2015 Subanalysis of the Long-Term Clinical Outcomes Survey \u2015"],"prefix":"10.1253","volume":"83","author":[{"given":"Keisuke","family":"Shoji","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Yanishi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusuke","family":"Yoshimi","sequence":"additional","affiliation":[{"name":"Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Hamada","sequence":"additional","affiliation":[{"name":"Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuteru","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Hospital Organization Kumamoto Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Kuwahara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Shinshu University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihito","family":"Higashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Fukumoto","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiovascular Medicine, Kurume University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoaki","family":"Matoba","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"TACT Follow up Study Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). <i>J Vasc Surg<\/i> 2007; 45(Suppl S): S5\u2013S67.","DOI":"10.1016\/j.jvs.2006.12.037"},{"key":"2","unstructured":"2. Reidy ME, Steen V, Nicholas JJ. Lower extremity amputation in scleroderma. <i>Arch Phys Med Rehabil<\/i> 1992; 73: 811\u2013813."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, et al. Update of EULAR recommendations for the treatment of systemic sclerosis. <i>Ann Rheum Dis<\/i> 2017; 76: 1327\u20131339.","DOI":"10.1136\/annrheumdis-2016-209909"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. De Cata A, Inglese M, Molinaro F, De Cosmo S, Rubino R, Bernal M, et al. Digital ulcers in scleroderma patients: A retrospective observational study. <i>Int J Immunopathol Pharmacol<\/i> 2016; 29: 180\u2013187.","DOI":"10.1177\/0394632015606846"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Miyahara T, Suhara M, Nemoto Y, Shirasu T, Haga M, Mochizuki Y, et al. Long-term results of treatment for critical limb ischemia. <i>Ann Vasc Dis<\/i> 2015; 8: 192\u2013197.","DOI":"10.3400\/avd.oa.15-00074"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Deguchi J, Shigematsu K, Ota S, Kimura H, Fukuyama M, Miyata T. Surgical result of critical limb ischemia due to tibial arterial occlusion in patients with systemic scleroderma. <i>J Vasc Surg<\/i> 2009; 49: 918\u2013923.","DOI":"10.1016\/j.jvs.2008.10.066"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Harries RL, Ahmed M, Whitaker C, Majeed MU, Williams DT. The influence of connective tissue disease in the management of lower limb ischemia. <i>Ann Vasc Surg<\/i> 2014; 28: 1139\u20131142.","DOI":"10.1016\/j.avsg.2013.06.041"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Fujita Y, Kinoshita M, Furukawa Y, Nagano T, Hashimoto H, Hirami Y, et al. Phase II clinical trial of CD34+ cell therapy to explore endpoint selection and timing in patients with critical limb ischemia. <i>Circ J<\/i> 2014; 78: 490\u2013501.","DOI":"10.1253\/circj.CJ-13-0864"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Liotta F, Annunziato F, Castellani S, Boddi M, Alterini B, Maggi E, et al. Therapeutic efficacy of autologous non-mobilized enriched circulating endothelial progenitors in patients with critical limb ischemia: The SCELTA trial. <i>Circ J<\/i> 2018; 82: 1688\u20131698.","DOI":"10.1253\/circj.CJ-17-0720"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Horie T, Yamazaki S, Hanada S, Kobayashi S, Tsukamoto T, Fukushima M, et al. Outcome from a randomized controlled clinical trial: Improvement of peripheral arterial disease by granulocyte colony-stimulating factor-mobilized autologous peripheral-blood-mononuclear cell transplantation (IMPACT). <i>Circ J<\/i> 2018; 82: 2165\u20132174.","DOI":"10.1253\/circj.CJ-17-1220"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: A pilot study and a randomised controlled trial. <i>Lancet<\/i> 2002; 360: 427\u2013435.","DOI":"10.1016\/S0140-6736(02)09670-8"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Saigawa T, Kato K, Ozawa T, Toba K, Makiyama Y, Aizawa Y, et al. Clinical application of bone marrow implantation in patients with arteriosclerosis obliterans, and the association between efficacy and the number of implanted bone marrow cells. <i>Circ J<\/i> 2004; 68: 1189\u20131193.","DOI":"10.1253\/circj.68.1189"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Matoba S, Tatsumi T, Murohara T, Imaizumi T, Katsuda Y, Ito M, et al. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia. <i>Am Heart J<\/i> 2008; 156: 1010\u20131018.","DOI":"10.1016\/j.ahj.2008.06.025"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Idei N, Soga J, Hata T, Fujii Y, Fujimura N, Mikami S, et al. Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: A comparison of atherosclerotic peripheral arterial disease and Buerger disease. <i>Circ Cardiovasc Interv<\/i> 2011; 4: 15\u201325.","DOI":"10.1161\/CIRCINTERVENTIONS.110.955724"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Pignon B, Sevestre MA, Kanagaratnam L, Pernod G, Stephan D, Nguyen P, et al. Autologous bone marrow mononuclear cell implantation and its impact on the outcome of patients with critical limb ischemia: Results of a randomized, double-blind, placebo-controlled trial. <i>Circ J<\/i> 2017; 81: 1713\u20131720.","DOI":"10.1253\/circj.CJ-17-0045"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kondo K, Yanishi K, Hayashida R, Shintani S, Shibata R, Matoba S, et al. Long-term clinical outcomes survey of bone marrow-derived cell therapy in critical limb ischemia in Japan. <i>Circ J<\/i> 2018; 82: 1168\u20131178.","DOI":"10.1253\/circj.CJ-17-0510"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kao L, Weyand C. Vasculitis in systemic sclerosis. <i>Int J Rheumatol<\/i> 2010; 2010: 3859938.","DOI":"10.1155\/2010\/385938"},{"key":"18","unstructured":"18. Adigun R, Bhimji SS. Systemic sclerosis (CREST syndrome). StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing, 2018\u20132017 Apr 19. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK430875 (accessed August 30, 2018)."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). <i>Am J Med<\/i> 1972; 52: 148\u2013159.","DOI":"10.1016\/0002-9343(72)90064-2"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Grader-Beck T, Wigley FM. Raynaud\u2019s phenomenon in mixed connective tissue disease. <i>Rheum Dis Clin North Am<\/i> 2005; 31: 465\u2013481.","DOI":"10.1016\/j.rdc.2005.04.006"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Schiopu E, Impens AJ, Phillips K. Digital ischemia in scleroderma spectrum of diseases. <i>Int J Rheumatol<\/i>, doi:10.1155\/2010\/923743.","DOI":"10.1155\/2010\/923743"},{"key":"22","unstructured":"22. Ingraham KM, Steen VD. Morbidity of digital tip ulcerations in scleroderma (abstract). <i>Arthritis Rheum<\/i> 2006; 54: P578."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Wigley FM, Wise RA, Seibold JR, McCloskey DA, Kujala G, Medsger TA, et al. Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis: A multicenter, placebo-controlled, double-blind study. <i>Ann Intern Med<\/i> 1994; 120: 199\u2013206.","DOI":"10.7326\/0003-4819-120-3-199402010-00004"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Tingey T, Shu J, Smuczek J, Pope J. Meta-analysis of healing and prevention of digital ulcers in systemic sclerosis. <i>Arthritis Care Res (Hoboken)<\/i> 2013; 65: 1460\u20131471.","DOI":"10.1002\/acr.22018"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Korn JH, Mayes M, Matucci Cerinic M, Rainisio M, Pope J, Hachulla E, et al. Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist. <i>Arthritis Rheum<\/i> 2004; 50: 3985\u20133993.","DOI":"10.1002\/art.20676"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Matucci-Cerinic M, Denton CP, Furst DE, Mayes MD, Hsu VM, Carpentier P, et al. Bosentan treatment of digital ulcers related to systemic sclerosis: Results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial. <i>Ann Rheum Dis<\/i> 2011; 70: 32\u201338.","DOI":"10.1136\/ard.2010.130658"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Steen V, Denton CP, Pope JE, Matucci-Cerinic M. Digital ulcers: Overt vascular disease in systemic sclerosis. <i>Rheumatology<\/i> 2009; 48: 19\u201324.","DOI":"10.1093\/rheumatology\/kep105"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Bohelay G, Blaise S, Levy P, Claeys A, Baudot N, Senet P, et al. Lower-limb ulcers in systemic sclerosis: A multicentre retrospective case\u2013control study. <i>Acta Derm Venereol<\/i> 2018; 98: 677\u2013682.","DOI":"10.2340\/00015555-2939"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Giuggioli D, Manfredi A, Lumetti F, Colaci M, Ferri C. Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature. <i>Autoimmun Rev<\/i> 2018; 17: 155\u2013164.","DOI":"10.1016\/j.autrev.2017.11.020"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC\/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): Executive summary. A collaborative report from the American Association for Vascular Surgery\/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC\/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. <i>J Am Coll Cardiol<\/i> 2006; 47: 1239\u20131312.","DOI":"10.1016\/j.jacc.2005.10.009"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Aboyans V, Ricco JB, Bartelink MEL, Bj\u00f6rck M, Brodmann M, Cohnert T, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). <i>Eur Heart J<\/i> 2018; 39: 763\u2013816.","DOI":"10.1093\/eurheartj\/ehx095"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. <i>Arthritis Rheum<\/i> 2003; 48: 2246\u20132255.","DOI":"10.1002\/art.11073"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. <i>Arthritis Rheum<\/i> 2000; 43: 2437\u20132444.","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Mihai C, Landew\u00e9 R, van der Heijde D, Walker UA, Constantin PI, Gherghe AM, et al. Digital ulcers predict a worse disease course in patients with systemic sclerosis. <i>Ann Rheum Dis<\/i> 2016; 75: 681\u2013686.","DOI":"10.1136\/annrheumdis-2014-205897"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Tolosa-Vilella C, Morera-Morales ML, Sime\u00f3n-Aznar CP, Mar\u00ed-Alfonso B, Colunga-Arguelles D, Callejas Rubio JL, et al. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry. <i>Semin Arthritis Rheum<\/i> 2016; 46: 200\u2013208.","DOI":"10.1016\/j.semarthrit.2016.04.007"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972\u20132002. <i>Ann Rheum Dis<\/i> 2007; 66: 940\u2013944.","DOI":"10.1136\/ard.2006.066068"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/83\/3\/83_CJ-18-1044\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T02:45:13Z","timestamp":1573872313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/83\/3\/83_CJ-18-1044\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,25]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-18-1044","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,25]]}}}